Smith, Moore & Co. Landec Corp \Ca\ Transaction History

Smith, Moore & Co.

  • $1.03 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
N/A
12,000 New
12,000 $0
Q2 2022

Aug 12, 2022
SELL
$8.84 - $11.64 $4,420 - $5,820
-500 Reduced 4.55%
10,500 $105,000
Q1 2022

May 12, 2022
BUY
$10.07 - $11.93 $10,070 - $11,930
1,000 Added 10.0%
11,000 $127,000
Q4 2021

Feb 08, 2022
BUY
$7.95 - $11.24 $79,500 - $112,400
10,000 New
10,000 $111,000

Others Institutions Holding LNDC

# of Institutions
80
Shares Held
20.4M
Call Options Held
65.8K
Put Options Held
14.1K
View Full List

About LANDEC CORP \CA\

LNDC Quotes by TradingView
  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Smith, Moore & Co. Portfolio

Follow Smith, Moore & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email